Reporting owner

ARCH Venture Fund VIII Overage, L.P.

Reporting owner CIK 0001617237 · 10% owner

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.ARCH Venture Fund VII, L.P.ARCH Venture Fund VII, L.P.ARCH Venture Partners VII, LLCARCH Venture Partners VII…ARCH Venture Partners VII, L.P.ARCH Venture Partners VII…ARCH Venture Partners VIII, LLCARCH Venture Partners VII…ARCH Venture Fund VIII Overage, L.P.ARCH Venture Fund VIII Ov…ARCH Venture Fund X, L.P.ARCH Venture Fund X, L.P.ARCH Venture Fund X Overage, L.P.ARCH Venture Fund X Overa…ARCH Venture Partners X Overage, L.P.ARCH Venture Partners X O…ARCH Venture Fund VII, L.P. · October 27, 2025 · Purchase · Common StockARCH Venture Partners VII, LLC · October 27, 2025 · Purchase · Common StockARCH Venture Partners VII, L.P. · October 27, 2025 · Purchase · Common StockARCH Venture Partners VIII, LLC · October 27, 2025 · Purchase · Common StockARCH Venture Fund VIII Overage, L.P. · October 27, 2025 · Purchase · Common StockARCH Venture Fund X, L.P. · October 27, 2025 · Purchase · Common StockARCH Venture Fund X Overage, L.P. · October 27, 2025 · Purchase · Common StockARCH Venture Partners X Overage, L.P. · October 27, 2025 · Purchase · Common StockOct 27, 2025Oct 27, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

1 dated transactions · 8 of 10 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Oct 27, 2025Neumora Therapeutics, Inc.Common StockARCH Venture Fund VII, L.P. · ARCH Venture Partners VII, LLC · ARCH Venture Partners VII, L.P. · ARCH Venture Partners VIII, LLC · ARCH Venture Fund VIII Overage, L.P. · ARCH Venture Fund X, L.P. · ARCH Venture Fund X Overage, L.P. · ARCH Venture Partners X Overage, L.P. · ARCH Venture Partners X, LLC · ARCH Venture Partners X, L.P.Purchase

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Neumora Therapeutics, Inc.NMRA · company listingsJoint filing · amounts unallocatedPurchaseCommon StockNon-derivative security · Code P1,915,7002.61Value: 4,999,977Currency not specifiedView ↗